COVID-19 Case Surveillance Restricted Access Detailed Data

<b>Note:</b>
Reporting of new COVID-19 Case Surveillance data will be discontinued July 1, 2024, to align with the process of removing SARS-CoV-2 infections (COVID-19 cases) from the list of nationally notifiable diseases. Although these data will continue to be publicly available, the dataset will no longer be updated. 

Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Kentucky (1/1/24), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death.


This case surveillance publicly available dataset has 33 elements for all COVID-19 cases shared with CDC and includes demographics, geography (county and state of residence), any exposure history, disease severity indicators and outcomes, and presence of any underlying medical conditions and risk behaviors. This dataset requires a registration process and a data use agreement.

<h4><b>CDC has three COVID-19 case surveillance datasets:</b></h4><ul><li><a href="https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Public-Use-Data-with-Ge/n8mc-b4w4">COVID-19 Case Surveillance Public Use Data with Geography</a>: Public use, patient-level dataset with clinical data (including symptoms), demographics, and county and state of residence. (19 data elements)</li><li><a href="https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Public-Use-Data/vbim-akqf">COVID-19 Case Surveillance Public Use Data</a>: Public use, patient-level dataset with clinical and symptom data and demographics, with no geographic data. (12 data elements)</li><li><a href="https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Restricted-Access-Detai/mbd7-r32t">COVID-19 Case Surveillance Restricted Access Detailed Data</a>: Restricted access, patient-level dataset with clinical and symptom data, demographics, and state and county of residence. Access requires a registration process and a data use agreement. (33 data elements)</li></ul>

<b>Requesting Access to the COVID-19 Case Surveillance Restricted Access Detailed Data</b>
Please review the following documents to determine your interest in accessing the COVID-19 Case Surveillance Restricted Access Detailed Data file:
1) <a href="https://data.cdc.gov/api/views/mbd7-r32t/files/9aad836e-5aa5-4047-aa5c-15996becc87c?download=true&filename=summary_guidance_and_limitations_information_and_restricted_access_data_use_agreement_information_updated.pdf"> CDC COVID-19 Case Surveillance Restricted Access Detailed Data: Summary, Guidance, Limitations Information, and Restricted Access Data Use Agreement Information</a>

2) <a href="https://data.cdc.gov/api/views/mbd7-r32t/files/4697b7f1-c0ea-403a-9583-6a02fd33a21c?download=true&filename=data_dictionary_covid_cases_restricted_detailed_updated.xlsx"> Data Dictionary for the COVID-19 Case Surveillance Restricted Access Detailed Data</a>

The next step is to complete the Registration Information and Data Use Restrictions Agreement (<a href="https://app.smartsheetgov.com/b/form/20e9cf9b42d04a92a67585043cf34fbe">RIDURA</a>). Once complete, CDC will review your agreement. After access is granted, Ask SRRG (<a href="mailto:eocevent394@cdc.gov">eocevent394@cdc.gov</a>) will email you information about how to access the data through GitHub. If you have questions about obtaining access, email <a href="mailto:eocevent394@cdc.gov">eocevent394@cdc.gov</a>. 

<h4><b>Overview</b></h4>

The COVID-19 case surveillance database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affili